Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$79.47 - $91.38 $39,735 - $45,690
-500 Reduced 17.86%
2,300 $202,000
Q1 2023

Apr 28, 2023

SELL
$76.72 - $87.58 $57,540 - $65,685
-750 Reduced 21.13%
2,800 $225,000
Q4 2022

Feb 09, 2023

SELL
$76.18 - $87.74 $77,017 - $88,705
-1,011 Reduced 22.17%
3,550 $275,000
Q3 2022

Nov 02, 2022

SELL
$80.75 - $95.31 $66,618 - $78,630
-825 Reduced 15.32%
4,561 $368,000
Q2 2022

Jul 21, 2022

SELL
$87.4 - $113.09 $40,204 - $52,021
-460 Reduced 7.87%
5,386 $483,000
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $7,040 - $7,866
70 Added 1.21%
5,846 $649,000
Q4 2021

Feb 09, 2022

BUY
$99.53 - $127.75 $32,347 - $41,518
325 Added 5.96%
5,776 $598,000
Q2 2021

Aug 13, 2021

SELL
$118.19 - $131.5 $65,004 - $72,325
-550 Reduced 9.17%
5,451 $677,000
Q1 2021

May 06, 2021

BUY
$111.18 - $119.74 $21,680 - $23,349
195 Added 3.36%
6,001 $786,000
Q4 2020

Jan 29, 2021

SELL
$100.57 - $117.14 $20,114 - $23,428
-200 Reduced 3.33%
5,806 $680,000
Q1 2020

Apr 22, 2020

BUY
$72.92 - $121.3 $40,106 - $66,715
550 Added 10.08%
6,006 $542,000
Q2 2019

Jul 25, 2019

BUY
$84.15 - $99.38 $19,354 - $22,857
230 Added 4.4%
5,456 $531,000
Q3 2018

Oct 25, 2018

SELL
$85.91 - $99.17 $18,041 - $20,825
-210 Reduced 3.86%
5,226 $514,000
Q2 2018

Jul 26, 2018

SELL
$77.48 - $87.83 $16,038 - $18,180
-207 Reduced 3.67%
5,436 $465,000
Q1 2018

May 04, 2018

SELL
$76.55 - $87.26 $1,760 - $2,006
-23 Reduced 0.41%
5,643 $453,000
Q4 2017

Jan 25, 2018

SELL
$76.93 - $83.5 $103,009 - $111,806
-1,339 Reduced 19.11%
5,666 $458,000
Q3 2017

Oct 31, 2017

BUY
$77.71 - $84.6 $544,358 - $592,623
7,005
7,005 $545,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Middleton & CO Inc Portfolio

Follow Middleton & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.